top of page

Dr Jacob Sands: New Small Cell Lung Cancer Treatments

Jacob Sands, MD

Thoracic Oncologist

Dana-Farber Cancer Institute


SCLC Meeting 12.20.2023





About the Speaker

Jacob Sands, MD is a thoracic medical oncologist at the Dana-Farber Cancer Institute where he treats patients with lung cancer and performs clinical research on lung cancer diagnostics and therapeutics. He leads the clinical small cell lung cancer program at the Dana-Farber Cancer Institute and serves on the NCCN guidelines committee for small cell lung cancer. Dr. Sands is a member of the Brigham and Women’s Hospital CT lung screening program and was a member of the Lahey CT lung screening steering committee while working there as a medical oncologist. He is a member of the NCCN guidelines committee on CT lung screening and the IASLC Screening & Early Detection Committee. Dr. Sands is a scientific advisory board member of the GO2 Foundation for Lung Cancer, a media spokesperson for the American Lung Association, and Treasurer of the Rescue Lung Rescue Life Society, a medical society focused on implementing lung screening and pioneering future innovations for early detection.


The LiveLung Small Cell Lung Cancer Program is supported in-part by grants from AstraZeneca, Amgen, and Jazz Pharmaceutical.


This Video Content has been made available for informational and educational purposes only. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.


LiveLung and speakers hereby disclaim any and all liability to any party for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising directly or indirectly from any use of the Video Content, which is provided as is, and without warranties.

Comentários


bottom of page